İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

ASUMAN DEMİROĞLU ZERGEROĞLU

PROFESÖR

GEBZE TEKNİK ÜNİVERSİTESİ TEMEL BİLİMLER FAKÜLTESİ MOLEKÜLER BİYOLOJİ VE GENETİK BÖLÜMÜ

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 30
  • Proje 0
  • Kitap 0
  • Bildiri 15
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 11 Q2 11 Q3 1 Q4 2
WoS (JCR) Q1 7 Q2 9 Q3 5 Q4 4
TR Index 0 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 0
Ort. yüzdelik 70.4%
Üst %1 payı 0.0%
Üst %10 payı 0.0%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 30 yayın

Scopus (SJR)
Q1 11 Q2 11 Q3 1 Q4 2
WoS (JCR)
Q1 7 Q2 9 Q3 5 Q4 4
TR Index
0 makale

Makale listesi

  1. 2025 Evaluation of the anticancer effects of hydroxycinnamic acid isomers on breast cancer stem cells Medical Oncology DOI 10.1007/s12032-025-02618-3 YÖKSİS SJR Q1 JCR Q2 OpenAlex 87.7%
  2. 2025 Exploration of the anticancer properties of Caffeic Acid in malignant mesothelioma cells Medical Oncology DOI 10.1007/s12032-025-02802-5 YÖKSİS SJR Q1 JCR Q2 OpenAlex 87.0%
  3. 2024 A network-based drug prioritization and combination analysis for the MEK5/ERK5 pathway in breast cancer BIODATA MINING DOI 10.1186/s13040-024-00357-1 YÖKSİS SJR Q1 JCR Q1 OpenAlex 71.5%
  4. 2023 2-Aminoanthraquinone substituted cyclotriphosphazene derivatives and their effect on non-small cell lung cancer cell lines Elsevier BV DOI 10.1016/j.ica.2023.121744 YÖKSİS SJR Q2 JCR Q2 OpenAlex 55.2%
  5. 2022 The first mono anthraquinone substituted monospiro cyclotriphosphazene derivatives and their effects on non-small cell lung cancer cells Elsevier BV DOI 10.1016/j.ica.2022.121002 YÖKSİS SJR Q2 JCR Q2 OpenAlex 84.3%
  6. 2022 Novel tetracyclic spermine derivatives of cyclotriphosphazene: Design, synthesis and biological activity Elsevier BV DOI 10.1016/j.molstruc.2022.132371 YÖKSİS SJR Q2 JCR Q2 OpenAlex 52.3%
  7. 2021 A systems pharmacology approach based on oncogenic signalling pathways to determine the mechanisms of action of natural products in breast cancer from transcriptome data BMC Complementary Medicine and Therapies. DOI 10.1186/s12906-021-03340-z YÖKSİS SJR Q1 JCR Q2 OpenAlex 83.3%
  8. 2020 Anticarcinogenic effects of halofuginone on lung-derived cancer cells Cell Biology International DOI 10.1002/cbin.11399 YÖKSİS SJR Q2 JCR Q3 OpenAlex 67.7%
  9. 2019 Targeting epidermal growth factor receptor pathway with irreversible tyrosine kinase inhibitor TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI DOI 10.1515/tjb-2017-0276 YÖKSİS SJR Q4 JCR Q4 OpenAlex 2.6%
  10. 2018 Investigation of potent anticarcinogenic activity of 1, 3-diarylpyrazole acrylamide derivatives in vitro Journal of Pharmacy and Pharmacology DOI 10.1111/jphp.13012 YÖKSİS SJR Q1 JCR Q3 OpenAlex 69.4%
  11. 2018 Effects of human sperm cryopreservation on apoptotic markers in normozoospermic and non-normozoospermic patients Zygote DOI 10.1017/S0967199418000254 YÖKSİS SJR Q4 JCR Q4 OpenAlex 80.5%
  12. 2017 Dicholoroacetate exerts anti-cancer activity on human renal cell carcinoma cells TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI DOI 10.1515/tjb-2016-0203 YÖKSİS SJR Q3 JCR Q4 OpenAlex 40.0%
  13. 2016 Quercetin and Cisplatin combined treatment altered cell cycle and mitogen activated protein kinase expressions in malignant mesotelioma cells BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE DOI 10.1186/s12906-016-1267-x YÖKSİS SJR Q1 JCR Q1 OpenAlex 87.9%
  14. 2016 EGFR-dependent signalling reduced and p38 dependent apoptosis required by Gallic acid in Malignant Mesothelioma cells Biomedicine & Pharmacotherapy DOI 10.1016/j.biopha.2016.11.005 YÖKSİS SJR Q2 JCR Q2 OpenAlex 84.6%
  15. 2016 Eradicating Quiescent Tumor Cells by Targeting Mitochondrial Bioenergetics TRENDS IN CANCER DOI 10.1016/j.trecan.2016.10.009 YÖKSİS SJR Q1 JCR Q1 OpenAlex 62.7%
  16. 2024 A network‑based drug prioritization and combination analysis for the MEK5/ERK5 pathway in breast cancer Bio Data Mining DOI https://biodatamining.biomedcentral.com/ YÖKSİS SJR Q1 JCR Q1
  17. 2024 Preliminary evaluation of antiproliferative and apoptotic activities of novel indolin-2-one derivatives Drug Development Research DOI https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/ddr.22229 YÖKSİS SJR Q2 JCR Q1
  18. 2020 Anti-carcinogenic effects of Halofuginone on lung derivedcancer cells CELL BIOLOGY INTERNATIONAL YÖKSİS SJR Q2 JCR Q3
  19. 2020 Quercetin Enhances Human Sperm Motility in a Dose and Time Dependent Manner ACTA Pharmaceutica Sciencia DOI 10.23893/1307-2080.APS.05810 YÖKSİS OpenAlex 80.0%
  20. 2019 Thiazole substituted dispiromonoansa and monospiro cyclotriphosphazenes: Design, synthesis and biological activity Inorganica Chimica Acta DOI 10.1016/j.ica.2019.119158 YÖKSİS SJR Q2 JCR Q2 OpenAlex 58.1%

Akademisyenlere dön